Tagged albumin-bound-or-nab-paclitaxel
Press Release
Consumer Safety Watch Warns Paclitaxel Weekly More Effective, Has Fewer Side Effects Than Docetaxel for Women Diagnosed With Breast Cancer That Had Spread to the Lymph Nodes
In this study of 5,000 women, more women who received Paclitaxel once a week were likely to be alive and free of breast cancer five years after being diagnosed compared to women who received Paclitaxel every three weeks OR women who received Docetaxel (either weekly or every three weeks).
Read More